Posted in Uncategorized

The following announcement replaces the announcement released on 30 May 2018 at 18:30 (UK time) under RNS number 7508P.

Replacement Announcement – Novacyt 30-11-18

Visit Page
Posted in Board, Novacyt Group, NOVAPREP®, Products, Services, Uncategorized

NOVACYT SIGNS $3.0M DIAGNOSTICS SUPPLY AGREEMENT WITH GENESIS DIAGNOSTICS

PrimerDesign Genesis Diagnostics ENG Paris, France and Camberley, UK – 27th November 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its molecular testing division, Primerdesign Ltd. (Primerdesign), has signed an exclusive supply agreement worth a minimum of $3 million with Genesis Diagnostics, a US-based full service diagnostic

Visit Page
Posted in Board, Novacyt Group, NOVAPREP®, Products, Services, Uncategorized

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL

Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers http://novacyt.com/wp-content/uploads/2018/11/NOVACYT_CP_Droits-de-vote_2018-Nov.pdf

Visit Page